Bovine Pepsinogen and Pepsin

Previous experiments have suggested that a substrate binding site may appear relatively early in the sequence of transformations that pepsinogen undergoes during its unimolecular activation. To test this possibility, tert-Boc-L-valyl-[3(S)-hydroxy-4(S)-amino-5-(2-naphthyl) pentanoyl]-L-alanylisoamylamide, a fluorescent analogue of pepstatin, has been used to measure the rate of appearance of the binding site. This probe is a potent inhibitor of pepsin, and its naphthyl group is an environmentally sensitive fluorophore that permits binding to be detected by fluorescence spectroscopy. In stopped-flow experiments, the fluorescence change following acidification of pepsinogen due to binding of the probe was found to obey a two-term exponential decay law. Analysis of the data obtained at various pH values permits us to rule out a sequential model for the kinetics. Rather, we were able to demonstrate that a concurrent model, with two species undergoing simultaneous transformation at different rates, is consistent with the results. The two species are related to each other by the protonation of a single site with a pKa of approximately 2.2. We obtained essentially identical results in an analysis of the early events observed in the acidification of pepsinogen labeled with 6-(p-toluidinyl)naphthalene-2-sulfonyl chloride (Auer & Glick, 1984). The protonic equilibrium probably occurs early after exposure to acid and is proposed to lead to a conformational change that freezes the distribution between the two species. It may be that these two conformers persist as identifiable entities at later stages of activation as well.(ABSTRACT TRUNCATED AT 250 WORDS)

Section: Methodsmentioning

confidence: 99%

Pepsinogen activation: genesis of the binding site

Glick¹,

Auer²,

Rich³

et al. 1986

“…General Methods. Pepsin activity was assayed according to Chow & Kassell (1968), and activation of pepsinogen was followed by the method of Al-Janabi et al (1972). Amino acid analysis was performed on a Dionex instrument.…”

Section: Methodsmentioning

confidence: 99%

Early events of pepsinogen activation

Auer¹,

Glick²

1984

Stopped-flow measurements both with native pig pepsinogen and with a fluorescent derivative, labeled near the carboxyl terminus with a toluidinylnaphthalenesulfonyl (TNS) group at Lys364, show rapid fluorescence changes following acidification. The rate constants observed by intrinsic fluorescence of the native zymogen are distinctly greater than those exhibited by the TNS derivative in the pH range examined. The rate constants for two early events in the activation of the derivative increase as the pH decreases from pH 3 to pH 2. The fluorescent intensities of these two processes also vary with pH. Because the ratios of these amplitudes fit the Henderson-Hasselbalch equation, it is concluded that the two processes represent concurrent events, rather than sequential ones. It is proposed that a protonation separates two forms of the zymogen. The conjugate acid undergoes the slower event, whereas the conjugate base, which predominates at pH 3, undergoes the faster event. It is proposed that both these pathways result in activation.

“…The enzyme-inhibitor complex was first formed by incubating 0.3 nmol (10 µg) of porcine pepsin with either 3.3 nmol of native peptide or 1.6 nmol of guanidinated peptide in 0.25 mL of 0.2 M sodium acetate buffer, pH 5.3, for 15 min at 37 °C. The pH was adjusted to 7.0, where pepsin alone is rapidly denatured, and the solution was incubated for 10 min before adjustment to pH 2 for hemoglobin assay (Anson, 1939; Chow and Kassell, 1968) of remaining peptic activity. Controls were treated in the same manner, except that buffer of pH 5.3 was used instead of the peptides.…”

Section: Methodsmentioning

confidence: 99%

Improved pepsin inhibitor derived from activation peptide 1-16 of porcine pepsinogen

Pm¹,

Kassell²

1977

The peptide Leu-Val-Lys-Val-Pro-Leu-Val-Arg-Lys-Lys-Ser-Leu-Arg-Gln-Asn-Leu, a known pepsin inhibitor, is derived from the first 16 amino acids of porcine pepsinogen. It was prepared from the activation mixture and was modified by guanidination of its three lysine residues to form homoarginine residues. The modified peptide is a better pepsin inhibitor than the native peptide; for 50% inhibition of the milk clotting action of pepsin at pH 5.3, the molar ratio of peptide to pepsin required is 9 for the native inhibitor and only 2 for the guanidinated inhibitor. The dissociation constants (k1) of the inhibitor-pepsin complexes are 7 X 10(-8) and 1.4 X 10(-8) M for the native and guanidinated peptides, respectively. The guanidinated peptide is more resistant to digestion by pepsin at pH 3.5. The native and modified peptides partially protect pepsin from inactivation at pH 7. Stepwise removal of the amino-terminal Leu-Val-Har residues from the guanidinated inhibitor by Edman degradation decreases the pepsin-inhibiting activity only slightly at the first step, but markedly at the second and third steps. Thus, all of the amino-terminal sequence except the leucine residue is necessary for full activity.